Lipoxysan – a liposomal formulation of SOD for transdermal application

Lipoxysanâ a liposomal formulation of the recombinant, human Cu/Zn Superoxide Dismutase, prepared with the Cross-Flow-Injection Techniqueâ, will be optimised and several batches will be prepared in pharmaceutical quality. To proof the potency of this lipsomal fomulation, two clinical trials will be performed. First, a clinical study for the treatment of Peyronie Disease (IPP) will be carried out. The efficacy of Lipoxysan against the inflammatory response will be evaluated. In the second approach, studies with Lipoxysan to reduce post-burn edema and improvement in wound healing will be performed. The treatment will be evaluated in first and second degree burns.